NextFin News - U.S. equities still look like a reasonable place to allocate capital because the earnings backdrop has improved faster than many investors expected. FactSet said on July 31 that 86% of S&P 500 companies reporting actual results had posted positive EPS surprises, while 77% had beaten revenue estimates. The same update put the index’s blended second-quarter earnings growth rate at 47.4%, after a July 10 estimate of 23.6%. That sequence matters more than any single print: it shows a market where profits are not just strong, but still being revised higher as reports come in.
The immediate market reaction has been consistent with that message. On Aug. 3, U.S. stocks rose as investors refocused on earnings, with the S&P 500 closing 1.5% higher and the Nasdaq 100 up 1.8%, leaving the index near record highs. The market is therefore not debating whether U.S. corporations are delivering. It is debating how much of that delivery can still justify a premium valuation.
Wytenus’s point lands in that gap. If earnings are accelerating and revisions are still moving up, then the question is not whether U.S. stocks are cheap. It is whether the current earnings cycle is strong enough to keep making the U.S. look like the best large, liquid equity market to own. For now, the answer is yes, but with a caveat: the argument works best as a tactical and relative call, not as a claim that high valuations no longer matter.
Earnings Strength Is Doing More Than Just Beating Forecasts
The core fact is the revision path. FactSet said on July 10 that Q2 2026 S&P 500 earnings were expected to grow 23.6% year over year, versus 18.8% estimated on March 31. By July 31, the blended growth rate had reached 47.4%. Those are not small deltas. They show that the earnings season has been repricing the profit base higher almost in real time.
That is why the current allocation case is more than a headline beat rate story. A 86% EPS beat rate and 77% revenue beat rate imply that the market’s starting assumptions were too low across much of the index. When the beat is broad, not narrow, investors have a harder time dismissing it as a one-off effect from a handful of mega-cap names. The U.S. market is still heavily influenced by large technology franchises, but the breadth of the current season suggests the earnings story is wider than that.
There is a second layer here. Strong earnings do not only raise the present value of future cash flows; they also lower the perceived odds that the market will have to de-rate those cash flows soon. In practice, that means the earnings cycle can support a higher multiple even when the multiple already looks rich in absolute terms. Investors pay not only for profit growth, but also for the confidence that the growth is still underwritten by real demand, not just accounting momentum.
That explains why U.S. stocks have continued to attract capital despite repeated valuation debates. The S&P 500 closing 1.5% higher on Aug. 3 was not just a price move. It was the market’s way of saying that earnings still outrank valuation anxiety in the near term. The Nasdaq 100’s 1.8% rise reinforced that point: investors were willing to reward the most growth-sensitive part of the market because the reported numbers kept coming in better than expected.
The useful question now is whether this is cyclical momentum or a structural shift. The answer is both, but not in the same way. The surge in the blended growth rate is cyclical: it reflects a favorable earnings season, easier comparison bases, and a short-term revision cycle. But the reason U.S. equities keep attracting allocation is more structural. The U.S. still concentrates the largest global franchise businesses, the deepest capital markets, and the most important earnings engine in the world index complex. That structure does not guarantee upside, but it does make U.S. equities harder to replace than a simple valuation screen would suggest.
Why The Multiple Can Stay Elevated Even When It Looks Expensive
This is where second-order thinking matters. The first-order reaction to strong earnings is straightforward: profits are up, so stocks should hold up. The second-order effect is more interesting. When earnings come in well above expectations, forward estimates rise, and that can make today’s multiple look less demanding than it did before the reports. In other words, the market is not only paying for current results; it is constantly repricing the denominator.
That mechanism is why “reasonable” does not mean “cheap.” It means the price of the market can still be defended if the earnings base keeps ratcheting higher. FactSet’s July 10 and July 31 updates illustrate the point. The initial 23.6% growth estimate was already high by historical standards, and the eventual 47.4% blended growth rate showed that the quarter was turning out far better than the market had initially modeled. As long as that pattern holds, valuation pressure can be offset by earnings momentum.
The transmission channel runs through confidence. Strong earnings reduce the odds of an abrupt expectations reset, and a smaller expectations reset lowers the risk premium investors demand for holding equities. That is especially important in the U.S., where the market’s large-cap leaders are treated as global liquidity assets as much as domestic stocks. When those companies report well, the market is not just reacting to one quarter; it is reinforcing the idea that the U.S. remains the cleanest way to own growth at scale.
The market reaction supports that reading. On Aug. 3, investors moved back toward equities after focusing on earnings rather than macro headlines. The S&P 500 at a record-adjacent level means the market is still willing to give the earnings story the benefit of the doubt. That is a sign of resilience, but also a sign that investors are comfortable extending the earnings cycle as long as it keeps validating itself.
The strongest counter-thesis is that this is exactly what happens near peaks. A market can look healthy on the surface while becoming more dependent on a small number of winners, especially in technology and AI-linked names. If the good news is concentrated rather than broad, the index can still rise while the median stock does not participate nearly as much. In that case, the allocation case becomes fragile because the apparent strength rests on a narrowing base.
The falsifying signal is simple and quantifiable: if the beat rate falls back materially from 86%, if revenue surprises weaken from 77%, and if forward revisions stop climbing, then the argument for maintaining a U.S. overweight loses its central support. The market would then be paying for peak earnings momentum rather than durable earnings power.
“The market is not paying for perfection so much as for persistence.”
What Investors Are Really Buying: Time Horizon, Not Just Geography
The base case is that U.S. equities stay a reasonable allocation so long as earnings revisions keep moving higher and the market keeps treating strong reports as confirmation rather than climax. That favors large, liquid U.S. companies with visible pricing power and repeated beat potential. It also favors the index’s growth leaders because they are still the most direct beneficiaries of the current revision cycle.
The upside case is that the earnings run continues to broaden. If the rest of the season keeps producing outsized beats and upward revisions, then the market can defend a higher multiple for longer because the valuation debate will keep being displaced by profit momentum. In that scenario, the U.S. does not need to become cheap; it only needs to remain the market where earnings keep surprising to the upside.
The downside case is a quick normalization. If the beat rate fades, revenue surprises soften, or guidance starts to point toward flatter growth, the current allocation case will look less like a strategic conviction and more like a tactical trade that worked while earnings momentum lasted. That would not require a recession. It would only require the market to stop getting the kind of earnings support it has had through this season.
The near-term watch list is therefore clear: the next wave of quarterly results, the direction of forward revisions, and whether the index keeps producing broad revenue surprises rather than a few isolated outliers. Those are the signals that will tell investors whether the current U.S. allocation case is still gaining support or simply coasting on a strong first half of earnings season.
For now, the judgment is straightforward. The U.S. still looks like a reasonable place to allocate because earnings are doing enough to justify the premium, even if they are not doing enough to make the premium disappear.
The market’s case for America is not that it is cheap. It is that profits are still outrunning the argument against paying up.
Explore more exclusive insights at nextfin.ai.
